06Jun/13

ARCA biopharma's (ABIO) Gencaro Featured in Journal JACC: Heart Failure – StreetInsider.com (subscription)

ARCA biopharma’s (ABIO) Gencaro Featured in Journal JACC: Heart Failure
StreetInsider.com (subscription)
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that the paper “Prevention of Atrial Fibrillation by Bucindolol is Dependent on the Beta-1 389

and more »

05Jun/13

Heart failure guidelines- New hope in medical therapy – Family Practice News Digital Network

Heart failure guidelines- New hope in medical therapy
Family Practice News Digital Network
The newest heart failure management guidelines make a bold statement: Heart failure should no longer be considered a death sentence, but can instead be managed in a way that may add years of quality life for some patients. “With optimal therapy applied
ACC, AHA release guideline for treating heart failureNurse.com
Stingfellow Memorial Hospital receives American Heart Association awardThe Birmingham News – al.com

all 3 news articles »

05Jun/13

Research and Markets: Hyperphosphatemia in Chronic Kidney Disease … – Wall Street Journal (press release)

Research and Markets: Hyperphosphatemia in Chronic Kidney Disease
Wall Street Journal (press release)
Research and Markets (http://www.researchandmarkets.com/research/99w828/hyperphosphatemia) has announced the addition of the “Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2013″ report to their offering. Global Markets

and more »